The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study
Publication
, Conference
Bailey, D; Chan, D; Roach, P; Schembri, G; Bernard, E; Hsiao, E; Hayes, A; Khasraw, M; Samra, J; Pavlakis, N
Published in: JOURNAL OF NUCLEAR MEDICINE
May 1, 2019
Duke Scholars
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
May 1, 2019
Volume
60
Location
Anaheim, CA
Publisher
SOC NUCLEAR MEDICINE INC
Conference Name
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI)
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bailey, D., Chan, D., Roach, P., Schembri, G., Bernard, E., Hsiao, E., … Pavlakis, N. (2019). The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study. In JOURNAL OF NUCLEAR MEDICINE (Vol. 60). Anaheim, CA: SOC NUCLEAR MEDICINE INC.
Bailey, Dale, David Chan, Paul Roach, Geoffrey Schembri, Elizabeth Bernard, Edward Hsiao, Aimee Hayes, Mustafa Khasraw, Jaswinda Samra, and Nick Pavlakis. “The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study.” In JOURNAL OF NUCLEAR MEDICINE, Vol. 60. SOC NUCLEAR MEDICINE INC, 2019.
Bailey D, Chan D, Roach P, Schembri G, Bernard E, Hsiao E, et al. The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study. In: JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 2019.
Bailey, Dale, et al. “The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study.” JOURNAL OF NUCLEAR MEDICINE, vol. 60, SOC NUCLEAR MEDICINE INC, 2019.
Bailey D, Chan D, Roach P, Schembri G, Bernard E, Hsiao E, Hayes A, Khasraw M, Samra J, Pavlakis N. The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 2019.
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
May 1, 2019
Volume
60
Location
Anaheim, CA
Publisher
SOC NUCLEAR MEDICINE INC
Conference Name
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI)
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences